Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel TherapeuticsGlobeNewsWire • 07/31/23
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026GlobeNewsWire • 07/20/23
Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of DirectorsGlobeNewsWire • 04/04/23
Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™GlobeNewsWire • 02/22/23
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23GlobeNewsWire • 02/09/23
How Much Upside is Left in Codexis (CDXS)? Wall Street Analysts Think 219%Zacks Investment Research • 11/07/22
Codexis' 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the FieldGlobeNewsWire • 09/14/22
Codexis, Inc. (CDXS) CEO John Nicols on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/07/22
Analysts Estimate Codexis (CDXS) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/28/22